23.06.2025, 12:59

Polpharma to invest $62.6 mln in expansion of ChimPharm plant in Kazakhstan

ASTANA. June 23 (Interfax-Kazakhstan) - Polpharma Group will invest $62.6 million to expand the production capacity of its subsidiary ChimPharm JSC (SANTO), a pharmaceutical plant located in Shymkent, the press service of Kazakhstan’s government said in a Monday statement.

To read the full news articles, Subscribe.

05:46PM
Air Astana cancels flights to Doha, Dubai on June 24 amid escalation of Middle East conflict

05:36PM
Kazakhstan to receive first Stadler passenger railroad cars by end of 2025

05:35PM
Tokayev instructs Administration, Security Council to identify shortcomings in law enforcement system

05:20PM
ARDFM, banks to build system for early detection of money laundering, withdrawal schemes- Tokayev

05:15PM
Kazakhstan evacuates nearly 300 citizens from Iran and Israel

05:10PM
Kazakhstan to issue 2 dollar-denominated Eurobond issues with 7-, 12-year maturities, listing to take place on LSE, AIX, KASE

05:02PM
Kazakh President instructs to strengthen offense prevention

04:52PM
Kazakhstan aims to improve anti-money laundering practices to meet global standards

04:29PM
Interfax-Kazakhstan issues its 1066th Oil&Gas Report

04:05PM
AVERAGE WEIGHTED RATE ON JUNE 23, 2025 IS 523.46 TENGE FOR $1

04:03PM
Kazakhstan concerned over potential logistics disruptions amid Iran tensions